Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting

被引:59
|
作者
Iorio, Francesco [1 ,2 ,5 ]
Behan, Fiona M. [2 ,5 ]
Goncalves, Emanuel [2 ]
Bhosle, Shriram G. [2 ]
Chen, Elisabeth [2 ]
Shepherd, Rebecca [2 ]
Beaver, Charlotte [2 ]
Ansari, Rizwan [2 ]
Pooley, Rachel [2 ]
Wilkinson, Piers [2 ]
Harper, Sarah [2 ]
Butler, Adam P. [2 ]
Stronach, Euan A. [3 ,5 ]
Saez-Rodriguez, Julio [1 ,4 ,5 ,6 ]
Yusa, Kosuke [2 ]
Garnett, Mathew J. [2 ,5 ]
机构
[1] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England
[2] Wellcome Sanger Inst, Cambridge, England
[3] GlaxoSmithKline, Stevenage, Herts, England
[4] Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed Aachen, Fac Med, Aachen, Germany
[5] Open Targets, Cambridge, England
[6] Heidelberg Univ, Bioquant, Inst Computat Biomed, Fac Med, Heidelberg, Germany
来源
BMC GENOMICS | 2018年 / 19卷
基金
英国惠康基金;
关键词
CRISPR-Cas9; Genetic screens; Cancer; Gene copy number; Bias correction; CIRCULAR BINARY SEGMENTATION; DRUG-SENSITIVITY; GENOME; IDENTIFICATION; SCREENS; VULNERABILITIES; MARKERS;
D O I
10.1186/s12864-018-4989-y
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Genome editing by CRISPR-Cas9 technology allows large-scale screening of gene essentiality in cancer. A confounding factor when interpreting CRISPR-Cas9 screens is the high false-positive rate in detecting essential genes within copy number amplified regions of the genome. We have developed the computational tool CRISPRcleanR which is capable of identifying and correcting gene-independent responses to CRISPR-Cas9 targeting. CRISPRcleanR uses an unsupervised approach based on the segmentation of single-guide RNA fold change values across the genome, without making any assumption about the copy number status of the targeted genes. Results: Applying our method to existing and newly generated genome-wide essentiality profiles from 15 cancer cell lines, we demonstrate that CRISPRcleanR reduces false positives when calling essential genes, correcting biases within and outside of amplified regions, while maintaining true positive rates. Established cancer dependencies and essentiality signals of amplified cancer driver genes are detectable post-correction. CRISPRcleanR reports sgRNA fold changes and normalised read counts, is therefore compatible with downstream analysis tools, and works with multiple sgRNA libraries. Conclusions: CRISPRcleanR is a versatile open-source tool for the analysis of CRISPR-Cas9 knockout screens to identify essential genes.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
    Francesco Iorio
    Fiona M. Behan
    Emanuel Gonçalves
    Shriram G. Bhosle
    Elisabeth Chen
    Rebecca Shepherd
    Charlotte Beaver
    Rizwan Ansari
    Rachel Pooley
    Piers Wilkinson
    Sarah Harper
    Adam P. Butler
    Euan A. Stronach
    Julio Saez-Rodriguez
    Kosuke Yusa
    Mathew J. Garnett
    BMC Genomics, 19
  • [2] Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
    Aguirre, Andrew J.
    Meyers, Robin M.
    Weir, Barbara A.
    Vazquez, Francisca
    Zhang, Cheng-Zhong
    Ben-David, Uri
    Cook, April
    Ha, Gavin
    Harrington, William F.
    Doshi, Mihir B.
    Kost-Alimova, Maria
    Gill, Stanley
    Xu, Han
    Ali, Levi D.
    Jiang, Guozhi
    Pantel, Sasha
    Lee, Yenarae
    Goodale, Amy
    Cherniack, Andrew D.
    Oh, Coyin
    Kryukov, Gregory
    Cowley, Glenn S.
    Garraway, Levi A.
    Stegmaier, Kimberly
    Roberts, Charles W.
    Golub, Todd R.
    Meyerson, Matthew
    Root, David E.
    Tsherniak, Aviad
    Hahn, William C.
    CANCER DISCOVERY, 2016, 6 (08) : 914 - 929
  • [3] Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects
    Goncalves, Emanuel
    Behan, Fiona M.
    Louzada, Sandra
    Arnol, Damien
    Stronach, Euan A.
    Yang, Fengtang
    Yusa, Kosuke
    Stegle, Oliver
    Iorio, Francesco
    Garnett, Mathew J.
    GENOME BIOLOGY, 2019, 20 (1)
  • [4] Highly Efficient Temperature Inducible CRISPR-Cas9 Gene Targeting in Drosophila suzukii
    Yan, Ying
    Kobayashi, Yukino
    Huang, Cong
    Liu, Bo
    Qian, Wanqiang
    Wan, Fanghao
    Schetelig, Marc F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [5] Minimal genome-wide human CRISPR-Cas9 library
    Goncalves, Emanuel
    Thomas, Mark
    Behan, Fiona M.
    Picco, Gabriele
    Pacini, Clare
    Allen, Felicity
    Vinceti, Alessandro
    Sharma, Mamta
    Jackson, David A.
    Price, Stacey
    Beaver, Charlotte M.
    Dovey, Oliver
    Parry-Smith, David
    Iorio, Francesco
    Parts, Leopold
    Yusa, Kosuke
    Garnett, Mathew J.
    GENOME BIOLOGY, 2021, 22 (01)
  • [6] Gene replacements and insertions in rice by intron targeting using CRISPR-Cas9
    Li, Jun
    Meng, Xiangbing
    Zong, Yuan
    Chen, Kunling
    Zhang, Huawei
    Liu, Jinxing
    Li, Jiayang
    Gao, Caixia
    NATURE PLANTS, 2016, 2 (10)
  • [7] Targeting cellular mRNAs translation by CRISPR-Cas9
    Liu, Yuchen
    Chen, Zhicong
    He, Anbang
    Zhan, Yonghao
    Li, Jianfa
    Liu, Li
    Wu, Hanwei
    Zhuang, Chengle
    Lin, Junhao
    Zhang, Qiaoxia
    Huang, Weiren
    SCIENTIFIC REPORTS, 2016, 6
  • [8] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) : 252 - 260
  • [9] CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
    Teh, Selina Shiqing K.
    Bowland, Kirsten
    Halper-Stromberg, Eitan
    Kotwal, Akhil
    Bennett, Alexis
    Skaist, Alyza
    Tang, Jacqueline
    Cai, Fidel
    Macoretta, Antonella
    Liang, Hong
    Kamiyama, Hirohiko
    Wheelan, Sarah
    Lin, Ming-Tseh
    Hruban, Ralph H.
    Hung, Chien-Fu
    Goldstein, Michael
    Scharpf, Robert B.
    Roberts, Nicholas J.
    Eshleman, James R.
    NAR CANCER, 2024, 6 (02):
  • [10] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204